A new systematic review and a 91-case series shed light on Aspergillus endophthalmitis
April 08 2020
Aspergillus endophthalmitis is difficult to treat and often results in poor outcomes. A recent systematic review (Spadea&Giannico, 2019) and a large series of 91 cases (Dave et al, 2020) provide an update on the most effective ways to diagnose and manage this serious condition.
Data are mounting for COVID-19 and Aspergillus co-infections
March 30 2020
***Updated 1/5/20*** Invasive pulmonary aspergillosis is a well-known complication of severe influenza, but it is not yet clear whether it could be a major co-infection in COVID-19 cases.
Loss of taste with terbinafine the most common side effect - FDA reports
March 23 2020
Wang & Lipman analysed 26 years' worth of adverse event reports made to the FDA for several antifungals, and found that taste disturbance was most common for terbinafine (12%).
Sexual problems and recurrent vulvovaginal candidiasis (rVVC)
March 11 2020
Recurrent vulvovaginal candidiasis (rVVC) is an unpleasant condition surrounded by taboos. Two new studies (one in Iran, one in São Paulo/New York) found lower quality of life and higher rates of depression among sufferers
Mucormycosis - 21 month, 12 centre prospective study in India finds 52% mortality
March 09 2020
A survey of 465 mucormycosis cases in India found a mortality rate of 52% over 90 days, and diabetes was the most important underlying condition in 74%